JP2024515880A5 - - Google Patents
Info
- Publication number
- JP2024515880A5 JP2024515880A5 JP2023566873A JP2023566873A JP2024515880A5 JP 2024515880 A5 JP2024515880 A5 JP 2024515880A5 JP 2023566873 A JP2023566873 A JP 2023566873A JP 2023566873 A JP2023566873 A JP 2023566873A JP 2024515880 A5 JP2024515880 A5 JP 2024515880A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- active
- composition
- composition according
- fragment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163182605P | 2021-04-30 | 2021-04-30 | |
| US63/182,605 | 2021-04-30 | ||
| PCT/US2022/026998 WO2022232552A1 (en) | 2021-04-30 | 2022-04-29 | Lipid nanoparticle therapeutics that evade the immune response |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024515880A JP2024515880A (ja) | 2024-04-10 |
| JP2024515880A5 true JP2024515880A5 (https=) | 2025-05-09 |
Family
ID=83848676
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023566873A Pending JP2024515880A (ja) | 2021-04-30 | 2022-04-29 | 免疫応答を回避する脂質ナノ粒子治療薬 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240226310A1 (https=) |
| EP (1) | EP4329816A1 (https=) |
| JP (1) | JP2024515880A (https=) |
| CN (1) | CN117425496A (https=) |
| AU (1) | AU2022264032A1 (https=) |
| CA (1) | CA3217121A1 (https=) |
| WO (1) | WO2022232552A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025059599A1 (en) * | 2023-09-13 | 2025-03-20 | Tessera Therapeutics, Inc. | Lipid nanoparticles for delivery of therapeutic payloads to cells |
| WO2025129106A1 (en) * | 2023-12-14 | 2025-06-19 | The Trustees Of The University Of Pennsylvania | Immunoevasive targeting molecules for efficient targeted delivery |
| WO2025166993A1 (zh) * | 2024-02-05 | 2025-08-14 | 复旦大学 | 一种新型脂质化合物以及组合物和核酸脂质纳米颗粒制剂及其筛选方法和应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11103462B2 (en) * | 2015-12-18 | 2021-08-31 | The Regents Of The University Of California | Protein nanocapsules with detachable zwitterionic coating for protein delivery |
| WO2018064350A1 (en) * | 2016-09-30 | 2018-04-05 | Eriochem Usa, Llc | Apo-e modified lipid nanoparticles for drug delivery to targeted tissues and therapeutic methods |
| CN110878127B (zh) * | 2018-09-06 | 2022-06-28 | 浙江柏拉阿图医药科技有限公司 | 长效重组GLP1-Fc-CD47蛋白及其制备和用途 |
| US20200093936A1 (en) * | 2018-09-21 | 2020-03-26 | The Trustees Of The University Of Pennsylvania | Therapeutic Targeting of Lipid Nanoparticles |
-
2022
- 2022-04-29 AU AU2022264032A patent/AU2022264032A1/en active Pending
- 2022-04-29 CN CN202280038633.4A patent/CN117425496A/zh active Pending
- 2022-04-29 CA CA3217121A patent/CA3217121A1/en active Pending
- 2022-04-29 EP EP22796834.4A patent/EP4329816A1/en active Pending
- 2022-04-29 US US18/558,013 patent/US20240226310A1/en active Pending
- 2022-04-29 JP JP2023566873A patent/JP2024515880A/ja active Pending
- 2022-04-29 WO PCT/US2022/026998 patent/WO2022232552A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024515880A5 (https=) | ||
| JP5914356B2 (ja) | インターフェロンアナログ | |
| Bansal et al. | Novel engineered targeted interferon‐gamma blocks hepatic fibrogenesis in mice | |
| ES2744225T3 (es) | Uso de polipéptidos de aprotinina como portadores en conjugados farmacéuticos | |
| JP5366352B2 (ja) | 抗原性が低下したポリマー結合体、その調製方法および使用方法 | |
| US20110052715A1 (en) | Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations and uses thereof | |
| JP2019038812A (ja) | ゴナドトロピンカルボキシ末端ペプチドに結合することによりポリペプチドの流体力学的体積を増加させる方法 | |
| JP2009519011A5 (https=) | ||
| JP2012067100A (ja) | Ｉｌ−２１の誘導体 | |
| WO1997048411A1 (en) | Medicinal compositions for treating liver diseases | |
| JP2025122021A5 (https=) | ||
| KR20130062953A (ko) | 안티센스 올리고뉴클레오티드를 포함하는 약학 조성물 및 이의 사용 방법 | |
| JP2017503022A (ja) | インビボで細胞に活性型テロメラーゼを提供する組成物および方法 | |
| Rodríguez-Castejón et al. | Targeting strategies with lipid vectors for nucleic acid supplementation therapy in Fabry disease: a systematic review | |
| US8791086B2 (en) | Polyion complex comprising PHD2 expression inhibiting substance | |
| JP2021176875A (ja) | ポリエチレングリコール（ｐｅｇ）−インターロイキン１１（ｉｌ−１１）コンジュゲートを生成するための反応中間体、および、ｐｅｇ−ｉｌ−１１コンジュゲートを精製する方法 | |
| WO2005035565A1 (en) | Il-21 derivatives | |
| JP2009513689A5 (https=) | ||
| ES2372728T3 (es) | Cicatrización de heridas mediante la administración de il-18 humana. | |
| KR102685034B1 (ko) | 금속 나노 입자-핵산 결합체를 기반으로 하는 유전자 운반체 | |
| JPWO2001080891A1 (ja) | 間質性肺炎治療薬および当該疾病の動物モデルの作成方法並びにそれを用いるスクリーニング方法 | |
| JP2022513626A5 (https=) | ||
| CN101119743B (zh) | 免疫增强剂 | |
| CN104136038A (zh) | 体腔积液抑制剂 | |
| WO2024065651A1 (zh) | 一种向adam10基因敲除的hek293细胞外泌体中装载二聚体cd24的方法 |